Streamlining Genetic Testing Claim Status Tracking

Klivira automates genetic testing claim status tracking, providing real-time visibility and proactive management for complex genomic services to optimize your revenue cycle.

Genetic testing, encompassing high-cost services like hereditary cancer panels, prenatal genetic testing, and pharmacogenomics, presents unique challenges in claim processing. Manual claim status tracking for these specialized services, often managed by RBMs such as eviCore and Avalon Healthcare Services, leads to significant administrative burden and increased risk of revenue loss due to delayed follow-up or timely-filing breaches.

The Challenge of Genetic Testing Claim Status

The high cost and clinical complexity of genetic tests necessitate meticulous claim management. Without automated systems, staff must manually poll multiple payer portals or call centers for claim status, interpreting varied responses for high-value claims like hereditary cancer panels. This manual overhead for each genomic claim, especially when managed by specific RBMs, diverts resources and increases the likelihood of claims languishing in 'pending' status beyond critical follow-up windows, impacting cash flow and patient access.

Klivira's Automated Claim Status Tracking for Genetic Services

Klivira's platform provides a robust solution for genetic testing claim status tracking, integrating directly with payers and EMRs to automate inquiries and consolidate information. Our system eliminates the need for manual polling, offering a unified view of claim status for all genetic tests, from initial submission to final adjudication. This automation is critical for managing the lifecycle of complex genetic claims, ensuring no high-value service is overlooked.

Key Capabilities for Genetic Testing Claim Management

**Automated X12 277 Polling**: Klivira automatically queries payer claim status via X12 277 transactions on configurable schedules, with intelligent backoff for stable claims and aggressive polling for those requiring attention.
**FHIR ClaimResponse Integration**: For payers leveraging FHIR-based claim flows, Klivira consumes ClaimResponse resources as part of the Da Vinci PAS umbrella, ensuring comprehensive status updates.
**Normalized Status Taxonomy**: Payer-specific status codes are normalized into a uniform claim-state model, eliminating interpretation variability for genetic testing claims.
**Stuck-Claim Escalation**: Claims pending beyond configurable thresholds trigger automated follow-up workflows, preventing high-cost genetic test claims from exceeding timely-filing limits.
**PA-to-Claim Linkage**: Klivira maintains a critical link between the prior authorization (PA) for a genetic test and its subsequent claim, identifying discrepancies between authorized services and billed claims.

Preventing Revenue Leakage for Genomic Services

The financial impact of unmanaged genetic testing claims can be substantial. Automated claim status tracking is a direct countermeasure to common revenue cycle challenges, such as claims being denied due to timely-filing errors or requiring extensive manual rework. By proactively identifying and escalating 'stuck' claims, Klivira helps prevent write-offs and accelerates the adjudication process for high-value hereditary cancer panels, prenatal tests, and pharmacogenomic services.

Standards and Interoperability for Genetic Testing Claims

Klivira adheres to industry standards, utilizing X12 277 for claim status requests and responses, and ingesting X12 835 for remittance advice. Furthermore, our platform integrates with FHIR ClaimResponse for advanced interoperability with payers participating in Da Vinci PAS initiatives. This multi-standard approach ensures robust connectivity across diverse payer channels, critical for the varied landscape of genetic testing prior authorizations and claims.

Frequently asked questions

How does Klivira handle claim status for genetic tests managed by RBMs like eviCore or Avalon?

Klivira integrates with various payer and RBM channels, including those frequently used for genetic testing prior authorizations. Our automated X12 277 polling and normalized status taxonomy are designed to retrieve and interpret claim status information consistently, regardless of the specific RBM or payer portal.

Can Klivira track the prior authorization status alongside the claim status for genetic testing?

Yes, Klivira maintains a direct linkage between the prior authorization and the subsequent claim. This PA-to-claim linkage is crucial for genetic testing, allowing your team to identify if a billed service aligns with the authorized genetic test and proactively address any discrepancies that could lead to denials.

What happens if a genetic testing claim gets 'stuck' in a pending status for too long?

Klivira's system includes configurable escalation rules for 'stuck' claims. If a genetic testing claim remains in a pending or review status beyond a defined threshold, the platform automatically triggers follow-up workflows, such as generating alerts for your team or initiating automated payer outreach, to prevent timely-filing breaches.

How does Klivira normalize claim status codes for complex genetic tests?

Payer-specific claim status codes, which can vary significantly, are normalized by Klivira into a uniform, clear claim-state model. This standardization eliminates ambiguity and ensures that your revenue cycle team has a consistent understanding of the status for all genetic testing claims, regardless of the originating payer or RBM.